UroGen Pharma Ltd.
URGN
$18.44
-$0.35-1.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.11% | -49.10% | -34.89% | 19.41% | 72.80% |
| Total Receivables | 62.95% | -13.59% | 12.83% | 38.71% | 31.46% |
| Inventory | 78.43% | 9.84% | -4.22% | 4.79% | 62.65% |
| Prepaid Expenses | 65.88% | -13.74% | -1.25% | 23.75% | -13.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.46% | 25.54% | 31.15% | 30.74% | 31.06% |
| Total Current Assets | -32.63% | -42.88% | -29.43% | 20.54% | 63.21% |
|
|
|||||
| Total Current Assets | -32.63% | -42.88% | -29.43% | 20.54% | 63.21% |
| Net Property, Plant & Equipment | 139.98% | 453.25% | 240.93% | 167.79% | 60.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 597.78% | 1,172.66% | 15.33% | -58.69% | -66.20% |
| Total Assets | -29.84% | -38.71% | -25.95% | 23.45% | 60.23% |
|
|
|||||
| Total Accounts Payable | 11.03% | 85.01% | 63.09% | 132.74% | 67.81% |
| Total Accrued Expenses | 7.48% | 16.62% | 30.32% | 34.58% | 29.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.71% | 92.48% | 94.47% | 81.51% | 86.81% |
| Total Finance Division Other Current Liabilities | -46.56% | 3.73% | 20.11% | 36.35% | 111.05% |
| Total Other Current Liabilities | -46.56% | 3.73% | 20.11% | 36.35% | 111.05% |
| Total Current Liabilities | 1.02% | 28.84% | 38.94% | 59.45% | 47.22% |
|
|
|||||
| Total Current Liabilities | 1.02% | 28.84% | 38.94% | 59.45% | 47.22% |
| Long-Term Debt | 0.39% | 0.33% | 25.25% | 25.12% | 23.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 270.36% | 2,843.87% | 703.06% | 346.00% | 95.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.79% | 6.69% | 8.02% | 9.46% | 10.86% |
| Total Liabilities | 3.88% | 8.69% | 20.10% | 22.17% | 20.94% |
|
|
|||||
| Common Stock & APIC | 7.13% | 3.01% | 4.03% | 19.66% | 29.84% |
| Retained Earnings | -19.04% | -21.42% | -20.80% | -19.45% | -18.68% |
| Treasury Stock & Other | -66.07% | -90.25% | 119.35% | 137.84% | 366.67% |
| Total Common Equity | -1,098.16% | -552.31% | -408.03% | -15.76% | 86.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1,098.16% | -552.31% | -408.03% | -15.76% | 86.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1,098.16% | -552.31% | -408.03% | -15.76% | 86.50% |
|
|
|||||